Share buy-back Programme COMPANY ANNOUNCEMENT NO 49/2018

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
64
Share buy-back Programme

COMPANY ANNOUNCEMENT NO 49/2018 –  13 AUGUST 2018

On 6 March 2018, Royal Unibrew initiated a share buy-back programme, cf. company announcement no. 15/2018 of 6 March 2018. The programme is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the Market Abuse Regulation - MAR) and the resulting delegated legislation. The share buy-back programme is expected to be realised in the period from 7 March 2018 to 22 February 2019. The total share buy-back in the period will not exceed a market price of DKK 400 million. The following transactions have been made under the programme:

  Number of Shares Average purchase price Transaction value, DKK
Accumulated, last announcement 617,979 445.10 275,061,126.89
6 August 2018 1,312 559.00 733,408.00
7 August 2018 2,500   557.30 1,393,250.00
8 August 2018 2,000 556.25 1,112,500.00
9 August 2018 0   0.00
10 August 2018 1,748 554.50 969,273.52
Accumulated under the programme 625,539 446.45 279,269,558.41

With the transactions stated above Royal Unibrew owns a total of 751,486 shares, corresponding to 1.5 % of the share capital. The total amount of shares in the company is 51,000,000, including treasury shares.

For further information on this Announcement: Lars Jensen, CFO, tel (+45) 29 23 00 44  www.royalunibrew.com

Encl.

Attachments

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es

Top 5 Most Recently Viewed Articles

Fujitsu Enhances ETF Trading with New ASX Partnership

Updated Category News Views 212

Fujitsu Partners with ASX for ETF Trading Innovation Fujitsu Limited is teaming up with the Australian Securities Exchange (ASX) and the Tokyo Stock Exchange (TSE) to create a state-of-the-art SaaS-based Request for Quote (RFQ) platform. This exciting initiative represents a significant step forward in modernizing the ETF trading landscape. Understanding the New RFQ...

Continue Reading
Owens Corning Reports Strong Earnings and Future Outlook

Updated Category News Views 177

Owens Corning Shows Strong Performance in Recent Quarter Owens Corning (NYSE: OC) has exceeded expectations with its recent earnings results, garnering significant attention from investors. The company reported exceptionally strong numbers from its latest earnings announcement, which prompted a notable increase in its stock price. The performance indicates solid...

Continue Reading
Research Links Chorioamnionitis to Preterm Birth Developments

Updated Category News Views 182

Chorioamnionitis and Its Impact on Early Birth Recent research emphasizes the severe implications of moderate to severe chorioamnionitis (HCA) associated with preterm births. Experts from Cincinnati Children's Hospital have confirmed that these infections not only trigger preterm deliveries but also lead to significant neurodevelopmental issues in early childhood. Study...

Continue Reading
Micron Shifts Focus: Exiting Consumer Market for AI Future

Updated Category News Views 305

Micron Technology's Significant Move Micron Technology, Inc. (NASDAQ: MU) has announced a strategic decision to exit its Crucial consumer business, ceasing the sale of Crucial-branded products through various global retailers and distributors. This transition marks a significant pivot aimed at refocusing efforts toward emerging market opportunities, especially in...

Continue Reading
China's COMAC Strives for Growth in Vietnam's Aviation Sector

Updated Category News Views 449

China's Ambitious Move into Vietnam's Aviation Market China's state-owned aircraft manufacturer, COMAC, is making significant strides to penetrate the international aviation market. The focus is currently on gaining approval for its C909 jets in Vietnam, a move indicative of a broader strategy to enhance its global presence. This initiative highlights the ongoing...

Continue Reading